Novabay制药 NBY 深 沪
等待开盘 03-26 09:30:00 美东时间
1.4799
-0.020
-1.34%
华盛通- 最 高1.65
- 今 开1.58
- 成交量 33.70万股
- 最 低 1.40
- 昨 收 1.50
- 总市值 3836.16万
- 52周最高 99.75
- 市盈率 静 --
- 换手率 1.30%
- 52周最低 -1.70
- 委 比 85.75%
- 总股本 2592.18万
- 历史最高 310839.75
- 量 比 0.74
- 振 幅 16.67%
- 历史最低 -1.70
- 每 手 1
- 风险率 13.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多NovaBay Pharma Rebrands, Pivoting Into Stablecoin Infrastructure
NovaBay Pharma ( ($NBY) ) has provided an announcement. On March 23, 2026, Nova...
03-23 20:58
NovaBay To Change Its Name To Stablecoin Development And Its NYSE American Ticker Symbol To SDEV
Following $134 million investment from R01 Fund LP, Framework Ventures, Tether Investments, S.A. de C.V., and Sky Frontier Foundation, Stablecoin Development Corporation has acquired 2.06 billion SKY tokensKey
03-23 20:35
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update
<p>Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.) has acquired 2.06 billion SKY tokens following a $134 million investment from R01 Fund LP, Framework Ventures, Tether Investments, and Sky Frontier Foundation. The company will change its name to Stablecoin Development Corporation and its ticker to SDEV on April 3, 2026. Key highlights include holding 8.78% of the total SKY supply, earning 26.6 million SKY tokens in st...
03-23 12:30
Eli Lilly and Co Stock Opened Up by 3.36% on Feb 23: What Investors Need To Know
• Novo Nordisk's experimental obesity drug trial failed, benefiting Eli Lilly. • FDA approved Eli Lilly's new multi-dose KwikPen for Zepbound. • Eli Lilly reported strong Q4 2025 earnings and optimistic 2026 guidance.
02-23 14:47
NovaBay Pharma Implements Reverse Stock Split of Shares
NovaBay Pharma ( ($NBY) ) just unveiled an announcement. On February 20, 2026, ...
02-21 05:54
NovaBay Pharmaceuticals Announces 1-for-5 Reverse Stock Split
NovaBay Pharmaceuticals Announces 1-for-5 Reverse Stock Split NovaBay Pharmaceuticals Inc. has announced a 1-for-5 reverse stock split of its common shares, effective as of February 20, 2026. The company's stock will begin trading on a split-adjusted basis on February 23, 2026. The move is intended
02-12 19:04
NovaBay Pharma Schedules Special Shareholder Meeting on Warrants
NovaBay Pharma ( ($NBY) ) has provided an announcement. NovaBay Pharmaceuticals...
01-31 06:29
Netflix, Erasca, Kraft Heinz And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around...
01-21 21:06
NovaBay plunges on sales agreement for $100M stock
NovaBay Pharmaceuticals (NBY) lost ~54% on Tuesday after the wound care product maker announced an at-the-market sales agreement with Virtu Americas, an institutional brokerage firm, to sell up to $10...
01-21 01:10
NovaBay Pharma Establishes $100 Million ATM Equity Program
NovaBay Pharma ( ($NBY) ) has shared an announcement. On January 20, 2026, Nova...
01-20 21:58
